14 July 2016Americas

Spectrum reaches patent settlement with Fresenius

US biopharmaceutical company Spectrum Pharmaceuticals announced yesterday that it had reached a settlement with UK healthcare company Fresenius Kabi in a patent dispute centring on the drug Folotyn (pralatrexate).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk